Symbols / TNON
TNON Chart
About
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 8.21M |
| Enterprise Value | 6.21M | Income | -12.81M | Sales | 3.23M |
| Book/sh | 0.20 | Cash/sh | 0.40 | Dividend Yield | — |
| Payout | 0.00% | Employees | 27 | IPO | — |
| P/E | 0.12 | Forward P/E | -0.76 | PEG | — |
| P/S | 2.54 | P/B | 3.69 | P/C | — |
| EV/EBITDA | -0.52 | EV/Sales | 1.92 | Quick Ratio | 1.56 |
| Current Ratio | 2.15 | Debt/Eq | 4.50 | LT Debt/Eq | — |
| EPS (ttm) | 5.92 | EPS next Y | -0.97 | EPS Growth | — |
| Revenue Growth | 32.20% | Earnings | 2026-03-19 | ROA | -65.80% |
| ROE | -197.26% | ROIC | — | Gross Margin | 52.40% |
| Oper. Margin | -222.76% | Profit Margin | 0.00% | Shs Outstand | 11.11M |
| Shs Float | 7.72M | Short Float | 0.72% | Short Ratio | 0.99 |
| Short Interest | — | 52W High | 5.85 | 52W Low | 0.64 |
| Beta | 1.28 | Avg Volume | 1.00M | Volume | 284.83K |
| Target Price | $2.75 | Recom | None | Prev Close | $0.71 |
| Price | $0.74 | Change | 3.76% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$2.75
Mean price target
2. Current target
$0.79
Latest analyst target
3. DCF / Fair value
$-11.13
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.79
Low
$2.50
High
$3.00
Mean
$2.75
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-04-09 | init | Alliance Global Partners | — → Buy | $3 |
| 2024-11-15 | main | Maxim Group | Buy → Buy | $8 |
| 2024-08-14 | reit | Benchmark | Speculative Buy → Speculative Buy | $3 |
| 2024-04-15 | main | Benchmark | Speculative Buy → Speculative Buy | $3 |
- Sacro-pelvic care company Tenon nearly doubles Q4 2025 revenue - Stock Titan Wed, 28 Jan 2026 08
- Tenon Medical Reaffirms Strong 2025 Revenue Growth Outlook - The Globe and Mail Sat, 07 Feb 2026 09
- Why retail investors pile into TNON stock - Market Performance Recap & Weekly Watchlist of Top Performers - mfd.ru Mon, 16 Feb 2026 06
- Tenon Medical CEO Foster buys $25k in TNON stock and warrants - Investing.com ue, 18 Nov 2025 08
- Tenon Medical reaffirms Q4 revenue up ~90% YoY, FY ~20% - Stock Titan hu, 05 Feb 2026 08
- Tenon Medical Reports Second Quarter 2025 Financial Results - Yahoo Finance Wed, 13 Aug 2025 07
- Curious about the stocks that are showing activity after the closing bell on Friday? - ChartMill Fri, 06 Feb 2026 22
- Tenon Medical Inc. Stock Surge: What’s Behind It? - StocksToTrade Fri, 01 Aug 2025 07
- Aug Volume: Is TNON stock overvalued or fairly priced - July 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn Wed, 11 Feb 2026 15
- Tenon Medical (TNON): chief commercial officer Grawey buys shares - Investing.com ue, 18 Nov 2025 08
- Why TNON stock remains resilient - July 2025 PostEarnings & Weekly Breakout Watchlists - mfd.ru Sat, 14 Feb 2026 13
- Tenon Medical(R) Announces Pricing of At-The-Market PIPE Financing - Yahoo Finance ue, 11 Nov 2025 08
- Tenon(R) Medical Issues Shareholder Letter and Provides Preliminary Revenue for the Fourth Quarter and Full Year 2025 - The Globe and Mail Wed, 28 Jan 2026 08
- Tenon Medical Expands Sacroiliac Joint Treatment with Game-Changing SiVantage Acquisition - Stock Titan Fri, 01 Aug 2025 07
- Tenon Medical stock falls after pricing $2.85M PIPE financing - Investing.com ue, 11 Nov 2025 08
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 64478 | — | — | FERRARI RICHARD M | Director | — | 2025-12-31 00:00:00 | D | nan |
| 1 | 10732 | — | — | WEIGLE ROBERT K. | Director | — | 2025-12-31 00:00:00 | D | nan |
| 2 | 10732 | — | — | HOCHSCHULER STEPHEN H | Director | — | 2025-12-31 00:00:00 | D | nan |
| 3 | 140936 | — | — | FOSTER STEVEN M | Chief Executive Officer | — | 2025-12-31 00:00:00 | D | nan |
| 4 | 10732 | — | — | HOWARD IVAN | Director | — | 2025-12-31 00:00:00 | D | nan |
| 5 | 126577 | — | — | GINN RICHARD | Chief Technology Officer | — | 2025-12-31 00:00:00 | D | nan |
| 6 | 10729 | — | — | JACQUES KRISTINE M | Director | — | 2025-12-31 00:00:00 | D | nan |
| 7 | 58987 | — | — | WILLIAMSON KEVIN | Chief Financial Officer | — | 2025-12-31 00:00:00 | D | nan |
| 8 | 19455 | — | Purchase at price 1.18 per share. | FOSTER STEVEN M | Chief Executive Officer | — | 2025-11-14 00:00:00 | D | 22957.0 |
| 9 | 19455 | — | Purchase at price 1.18 per share. | GEIST WYATT D. | Officer | — | 2025-11-14 00:00:00 | D | 22957.0 |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -13.17M | -15.30M | -18.45M | -6.35M |
| TotalUnusualItems | 183.00K | 167.00K | 180.00K | 2.00K |
| TotalUnusualItemsExcludingGoodwill | 183.00K | 167.00K | 180.00K | 2.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -13.67M | -15.58M | -18.92M | -7.05M |
| ReconciledDepreciation | 655.00K | 426.00K | 289.00K | 114.00K |
| ReconciledCostOfRevenue | 1.57M | 1.69M | 1.33M | 55.00K |
| EBITDA | -12.98M | -15.13M | -18.27M | -6.35M |
| EBIT | -13.64M | -15.56M | -18.56M | -6.46M |
| NetInterestIncome | -34.00K | -21.00K | -354.00K | -621.00K |
| InterestExpense | 34.00K | 21.00K | 354.00K | 621.00K |
| NormalizedIncome | -13.86M | -15.75M | -19.10M | -7.05M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -13.67M | -15.58M | -18.92M | -7.05M |
| TotalExpenses | 17.04M | 18.66M | 19.42M | 6.62M |
| TotalOperatingIncomeAsReported | -13.77M | -15.73M | -18.73M | -6.46M |
| DilutedAverageShares | 1.21M | 226.75K | 100.12K | 140.46K |
| BasicAverageShares | 1.21M | 226.75K | 100.12K | 140.46K |
| DilutedEPS | -11.26 | -68.72 | -188.96 | -50.18 |
| BasicEPS | -11.26 | -68.72 | -188.96 | -50.18 |
| DilutedNIAvailtoComStockholders | -13.67M | -15.58M | -18.92M | -7.05M |
| NetIncomeCommonStockholders | -13.67M | -15.58M | -18.92M | -7.05M |
| NetIncome | -13.67M | -15.58M | -18.92M | -7.05M |
| MinorityInterests | 0.00 | 33.00K | ||
| NetIncomeIncludingNoncontrollingInterests | -13.67M | -15.58M | -18.92M | -7.08M |
| NetIncomeContinuousOperations | -13.67M | -15.58M | -18.92M | -7.08M |
| PretaxIncome | -13.67M | -15.58M | -18.92M | -7.08M |
| OtherIncomeExpense | 127.00K | 167.00K | 162.00K | 1.00K |
| OtherNonOperatingIncomeExpenses | -56.00K | -18.00K | -1.00K | |
| GainOnSaleOfSecurity | 183.00K | 167.00K | 180.00K | 2.00K |
| NetNonOperatingInterestIncomeExpense | -34.00K | -21.00K | -354.00K | -621.00K |
| InterestExpenseNonOperating | 34.00K | 21.00K | 354.00K | 621.00K |
| OperatingIncome | -13.77M | -15.73M | -18.73M | -6.46M |
| OperatingExpense | 15.48M | 16.97M | 18.08M | 6.57M |
| ResearchAndDevelopment | 2.60M | 3.16M | 2.83M | 1.72M |
| SellingGeneralAndAdministration | 12.87M | 13.80M | 15.26M | 4.85M |
| SellingAndMarketingExpense | 5.11M | 6.78M | 7.83M | 2.14M |
| GeneralAndAdministrativeExpense | 7.76M | 7.03M | 7.42M | 2.71M |
| OtherGandA | 7.76M | 7.03M | 7.42M | 2.71M |
| GrossProfit | 1.71M | 1.24M | -641.00K | 105.00K |
| CostOfRevenue | 1.57M | 1.69M | 1.33M | 55.00K |
| TotalRevenue | 3.28M | 2.93M | 691.00K | 160.00K |
| OperatingRevenue | 3.28M | 2.93M | 691.00K | 160.00K |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 3.14M | 325.04K | 140.46K | 140.46K |
| ShareIssued | 3.14M | 325.04K | 140.46K | 140.46K |
| NetDebt | 10.59M | |||
| TotalDebt | 428.00K | 1.86M | 911.00K | 14.62M |
| TangibleBookValue | 2.22M | 778.00K | 6.25M | -20.55M |
| InvestedCapital | 2.22M | 1.95M | 6.25M | -7.05M |
| WorkingCapital | 6.34M | 749.00K | 6.82M | -7.60M |
| NetTangibleAssets | 5.97M | 778.00K | 6.25M | -20.55M |
| CapitalLeaseObligations | 428.00K | 684.00K | 911.00K | 1.11M |
| CommonStockEquity | 2.22M | 778.00K | 6.25M | -20.55M |
| PreferredStockEquity | 3.75M | |||
| TotalCapitalization | 5.97M | 778.00K | 6.25M | -20.55M |
| TotalEquityGrossMinorityInterest | 5.97M | 778.00K | 6.25M | -20.55M |
| MinorityInterest | 0.00 | 0.00 | ||
| StockholdersEquity | 5.97M | 778.00K | 6.25M | -20.55M |
| GainsLossesNotAffectingRetainedEarnings | 0.00 | -46.00K | -100.00K | -91.00K |
| OtherEquityAdjustments | -46.00K | -100.00K | -91.00K | |
| RetainedEarnings | -68.75M | -55.07M | -39.49M | -20.57M |
| AdditionalPaidInCapital | 70.96M | 55.90M | 45.84M | 113.00K |
| CapitalStock | 3.75M | 0.00 | 1.00K | 1.00K |
| CommonStock | 3.00K | 0.00 | 1.00K | 1.00K |
| PreferredStock | 3.75M | 0.00 | ||
| TotalLiabilitiesNetMinorityInterest | 3.87M | 5.57M | 4.84M | 29.82M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 2.00M | 2.43M | 2.31M | 14.55M |
| PreferredSecuritiesOutsideStockEquity | 0.00 | 13.64M | ||
| NonCurrentAccruedExpenses | 1.86M | 2.00M | 1.62M | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 141.00K | 428.00K | 683.00K | 911.00K |
| LongTermCapitalLeaseObligation | 141.00K | 428.00K | 683.00K | 911.00K |
| CurrentLiabilities | 1.87M | 3.14M | 2.53M | 15.27M |
| CurrentDebtAndCapitalLeaseObligation | 287.00K | 1.43M | 228.00K | 13.71M |
| CurrentCapitalLeaseObligation | 287.00K | 256.00K | 228.00K | 202.00K |
| CurrentDebt | 1.17M | 13.51M | ||
| OtherCurrentBorrowings | 1.17M | 13.51M | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 416.00K | 334.00K | 452.00K | 846.00K |
| PayablesAndAccruedExpenses | 1.17M | 1.38M | 1.85M | 720.00K |
| CurrentAccruedExpenses | 797.00K | 944.00K | 1.30M | 242.00K |
| Payables | 369.00K | 433.00K | 550.00K | 478.00K |
| AccountsPayable | 369.00K | 433.00K | 550.00K | 478.00K |
| TotalAssets | 9.84M | 6.34M | 11.09M | 9.27M |
| TotalNonCurrentAssets | 1.63M | 2.46M | 1.74M | 1.60M |
| NonCurrentPrepaidAssets | 51.00K | 51.00K | 51.00K | 41.00K |
| NonCurrentDeferredAssets | 431.00K | 798.00K | 25.00K | 374.00K |
| NetPPE | 1.15M | 1.61M | 1.67M | 1.19M |
| AccumulatedDepreciation | -668.00K | -273.00K | -80.00K | -2.00K |
| GrossPPE | 1.82M | 1.88M | 1.75M | 1.19M |
| Leases | 15.00K | 15.00K | 0.00 | |
| ConstructionInProgress | 541.00K | 602.00K | 601.00K | 0.00 |
| OtherProperties | 1.20M | 1.20M | 1.08M | 1.16M |
| MachineryFurnitureEquipment | 65.00K | 65.00K | 65.00K | 26.00K |
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 8.21M | 3.89M | 9.35M | 7.67M |
| OtherCurrentAssets | 206.00K | 389.00K | ||
| PrepaidAssets | 389.00K | 134.00K | 87.00K | |
| Inventory | 606.00K | 554.00K | 415.00K | 188.00K |
| FinishedGoods | 585.00K | 532.00K | 406.00K | 173.00K |
| RawMaterials | 21.00K | 22.00K | 9.00K | 15.00K |
| Receivables | 863.00K | 518.00K | 228.00K | 76.00K |
| AccountsReceivable | 863.00K | 518.00K | 228.00K | 76.00K |
| AllowanceForDoubtfulAccountsReceivable | 0.00 | 0.00 | 0.00 | |
| GrossAccountsReceivable | 518.00K | 228.00K | 76.00K | |
| CashCashEquivalentsAndShortTermInvestments | 6.54M | 2.43M | 8.57M | 7.32M |
| OtherShortTermInvestments | 0.00 | 6.44M | 4.40M | |
| CashAndCashEquivalents | 6.54M | 2.43M | 2.13M | 2.92M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -10.06M | -12.54M | -12.87M | -4.39M |
| RepaymentOfDebt | 0.00 | -245.00K | ||
| IssuanceOfDebt | 0.00 | 1.25M | 0.00 | 12.07M |
| IssuanceOfCapitalStock | 9.76M | 5.30M | 14.14M | 0.00 |
| CapitalExpenditure | -186.00K | -361.00K | -847.00K | -102.00K |
| InterestPaidSupplementalData | 0.00 | 0.00 | 1.00K | |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 1.00K | |
| EndCashPosition | 6.54M | 2.43M | 2.13M | 2.92M |
| BeginningCashPosition | 2.43M | 2.13M | 2.92M | 246.00K |
| EffectOfExchangeRateChanges | 46.00K | 38.00K | 7.00K | -2.00K |
| ChangesInCash | 4.06M | 261.00K | -795.00K | 2.67M |
| FinancingCashFlow | 14.12M | 6.30M | 14.11M | 11.47M |
| CashFlowFromContinuingFinancingActivities | 14.12M | 6.30M | 14.11M | 11.47M |
| NetOtherFinancingCharges | -1.10M | -509.00K | -25.00K | -358.00K |
| ProceedsFromStockOptionExercised | 5.46M | 258.00K | 0.00 | |
| NetPreferredStockIssuance | 3.15M | 0.00 | ||
| PreferredStockIssuance | 3.15M | 0.00 | ||
| NetCommonStockIssuance | 6.61M | 5.30M | 14.14M | 0.00 |
| CommonStockIssuance | 6.61M | 5.30M | 14.14M | 0.00 |
| NetIssuancePaymentsOfDebt | 0.00 | 1.25M | 0.00 | 11.83M |
| NetShortTermDebtIssuance | 0.00 | 1.25M | 0.00 | |
| ShortTermDebtIssuance | 0.00 | 1.25M | 0.00 | |
| NetLongTermDebtIssuance | 0.00 | 11.83M | ||
| LongTermDebtPayments | 0.00 | -245.00K | ||
| LongTermDebtIssuance | 0.00 | 12.07M | ||
| InvestingCashFlow | -186.00K | 6.14M | -2.88M | -4.50M |
| CashFlowFromContinuingInvestingActivities | -186.00K | 6.14M | -2.88M | -4.50M |
| NetInvestmentPurchaseAndSale | 0.00 | 6.50M | -2.04M | -4.40M |
| SaleOfInvestment | 0.00 | 7.00M | 8.08M | 0.00 |
| PurchaseOfInvestment | 0.00 | -493.00K | -10.12M | -4.40M |
| NetPPEPurchaseAndSale | -186.00K | -361.00K | -847.00K | -102.00K |
| PurchaseOfPPE | -186.00K | -361.00K | -847.00K | -102.00K |
| OperatingCashFlow | -9.88M | -12.18M | -12.03M | -4.29M |
| CashFlowFromContinuingOperatingActivities | -9.88M | -12.18M | -12.03M | -4.29M |
| ChangeInWorkingCapital | -746.00K | -1.17M | 1.72M | 452.00K |
| ChangeInOtherCurrentLiabilities | -256.00K | -227.00K | -202.00K | -82.00K |
| ChangeInPayablesAndAccruedExpense | -235.00K | -216.00K | 2.36M | 870.00K |
| ChangeInAccruedExpense | -171.00K | -99.00K | 2.29M | 426.00K |
| ChangeInPayable | -64.00K | -117.00K | 72.00K | 444.00K |
| ChangeInAccountPayable | -64.00K | -117.00K | 72.00K | 444.00K |
| ChangeInPrepaidAssets | 183.00K | -301.00K | -57.00K | -130.00K |
| ChangeInInventory | -52.00K | -139.00K | -227.00K | -145.00K |
| ChangeInReceivables | -386.00K | -290.00K | -152.00K | -61.00K |
| ChangesInAccountReceivables | -386.00K | -290.00K | -152.00K | -61.00K |
| OtherNonCashItems | 1.92M | 1.85M | ||
| StockBasedCompensation | 3.85M | 4.14M | 2.90M | 377.00K |
| UnrealizedGainLossOnInvestmentSecurities | 0.00 | -16.00K | -2.00K | |
| ProvisionandWriteOffofAssets | 41.00K | 0.00 | ||
| AssetImpairmentCharge | 0.00 | 77.00K | 0.00 | |
| DepreciationAmortizationDepletion | 655.00K | 426.00K | 289.00K | 114.00K |
| DepreciationAndAmortization | 655.00K | 426.00K | 289.00K | 114.00K |
| Depreciation | 655.00K | 426.00K | 289.00K | 114.00K |
| OperatingGainsLosses | -2.03K | |||
| GainLossOnInvestmentSecurities | -2.03K | |||
| NetIncomeFromContinuingOperations | -13.67M | -15.58M | -18.92M | -7.08M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for TNON
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|